Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type 2-mediated autoimmune disease

被引:59
作者
Biancone, L
Andres, G
Ahn, H
Lim, A
Dai, C
Noelle, R
Yagita, H
DeMartino, C
Stamenkovic, I
机构
[1] HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02129
[2] DARTMOUTH COLL SCH MED,DEPT MICROBIOL,LEBANON,NH 03756
[3] JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN
[4] IST DERMATOL S MARIA & S GALLICANO,I-00041 ROME,ITALY
关键词
D O I
10.1084/jem.183.4.1473
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We assessed the role of CD40-CD40L, cytotoxic T lymphocyte (CTL)A4/CD28-B7s, and CD2-CD48/CD58 lymphocyte costimulatory pathways in the development of mercury chloride (HgCl2)-induced autoimmune disease in mice, which is believed to be mediated by T helper (Th) subset Th2. Inhibition of CD40-CD40L and CTLA4/CD28-B7s interactions by anti-CD40L antibody and soluble CTLA4-immunoglobulin (Ig) fusion protein, respectively, abrogated the autoimmune disease without affecting interleukin 4 (IL-4) production, showing the importance of physical contact between T and B lymphocytes in the Th2-mediated process. In contrast, two anti-CD2 antibodies that have been shown to induce immunosuppression of Th1-mediated events exacerbated the autoantibody response and augmented IgG1, IgE, and IL-4 production, transforming a mild mesangial glomerulopathy into a severe systemic immune complex disease. These observations demonstrate that manipulation of lymphocyte accessory counterreceptor interactions may affect the course of Th2-associated autoimmune disease and suggest that signals resulting from CD2 engagement may play an essential role in the regulation of the Th1-Th2 effector equilibrium.
引用
收藏
页码:1473 / 1481
页数:9
相关论文
共 28 条
[1]   INHIBITION OF THE CD40-CD40LIGAND PATHWAY PREVENTS MURINE MEMBRANOUS GLOMERULONEPHRITIS [J].
BIANCONE, L ;
ANDRES, G ;
AHN, H ;
DEMARTINO, C ;
STAMENKOVIC, I .
KIDNEY INTERNATIONAL, 1995, 48 (02) :458-468
[2]   LESSONS FROM ANIMAL-MODELS - THE SCOPE OF MERCURY-INDUCED AUTOIMMUNITY [J].
BIGAZZI, PE .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 65 (02) :81-84
[3]  
BOGEN SA, 1993, J IMMUNOL, V150, P4197
[4]   ANTI-CD2 MONOCLONAL-ANTIBODIES ALTER CELL-MEDIATED-IMMUNITY INVIVO [J].
BROMBERG, JS ;
CHAVIN, KD ;
ALTEVOGT, P ;
KYEWSKI, BA ;
GUCKEL, B ;
NAJI, A ;
BARKER, CF .
TRANSPLANTATION, 1991, 51 (01) :219-225
[5]   PROLONGATION OF ALLOGRAFT AND XENOGRAFT SURVIVAL IN MICE BY ANTI-CD2 MONOCLONAL-ANTIBODIES [J].
CHAVIN, KD ;
LAU, HT ;
BROMBERG, JS .
TRANSPLANTATION, 1992, 54 (02) :286-291
[6]  
CHAVIN KD, 1994, J IMMUNOL, V152, P3729
[7]   LIGATION OF B7 WITH CD28 CTLA-4 ON T-CELLS RESULTS IN CD40 LIGAND EXPRESSION, INTERLEUKIN-4 SECRETION AND EFFICIENT HELP FOR ANTIBODY-PRODUCTION BY B-CELLS [J].
DEBOER, M ;
KASRAN, A ;
KWEKKEBOOM, J ;
WALTER, H ;
VANDENBERGHE, P ;
CEUPPENS, JL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) :3120-3125
[8]   CD30, TH2 CYTOKINES AND HIV-INFECTION - A COMPLEX AND FASCINATING LINK [J].
DELPRETE, G ;
MAGGI, E ;
PIZZOLO, G ;
ROMAGNANI, S .
IMMUNOLOGY TODAY, 1995, 16 (02) :76-80
[9]   THE ROLE OF CD40 IN THE REGULATION OF HUMORAL AND CELL-MEDIATED-IMMUNITY [J].
DURIE, FH ;
FOY, TM ;
MASTERS, SR ;
LAMAN, JD ;
NOELLE, RJ .
IMMUNOLOGY TODAY, 1994, 15 (09) :406-411
[10]   TH2 CELLS IN SYSTEMIC AUTOIMMUNITY - INSIGHTS FROM ALLOGENEIC DISEASES AND CHEMICALLY-INDUCED AUTOIMMUNITY [J].
GOLDMAN, M ;
DRUET, P ;
GLEICHMANN, E .
IMMUNOLOGY TODAY, 1991, 12 (07) :223-227